Quoted from http://www.bloomberg.com/news/2011-01-08/roche-sued-by-patient-claiming-cancer-from-pulled-psoriasis-drug-raptiva.html
Roche Sued by Patient Claiming Cancer From Pulled Psoriasis Drug Raptiva
By Laurel Brubaker Calkins - Jan 7, 2011 7:52 PM ET
Roche Holding AG’s Genentech Inc. was sued by a Texas psoriasis sufferer who alleges he developed lymphoma while taking Raptiva, a drug the company stopped selling in 2009 when studies linked it to a fatal brain infection.
Genentech, a unit of Basel, Switzerland-based drugmaker Roche, began a phased withdrawal of Raptiva in April 2009 after three patients taking it were diagnosed in the preceding six- month period with progressive multifocal leukoencephalopathy, or PML, a rare, incurable brain disease.
Houston-area psoriasis patient Cary Massa, 51, was diagnosed with classic Hodgkin’s lymphoma in March 2009, after taking Raptiva from February 2006 to January 2008, according to a complaint filed today in Houston federal court.